Radical prostatectomy in high-risk prostate cancer (Q57131976)

International Journal of Urology

Europe PubMed Central

title

Radical prostatectomy in high-risk prostate cancer (English)

0 references

1 reference

Joseph Ischia

1

0 references

Martin Gleave

series ordinal

2

0 references

language of work or name

English

0 references

publication date

March 2013

0 references

published in

0 references

volume

20

0 references

issue

3

0 references

page(s)

290-300

0 references

cites work

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

1 reference

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

21 January 2018

1 reference

High-risk prostate cancer in the United States, 1990-2007

21 January 2018

1 reference

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

21 January 2018

1 reference

Prostate cancer. Clinical practice guidelines in oncology

21 January 2018

1 reference

Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE).

21 January 2018

1 reference

What are the outcomes of radical prostatectomy for high-risk prostate cancer?

21 January 2018

1 reference

Treatment of patients with high risk localized prostate cancer: results from cancer of the prostate strategic urological research endeavor (CaPSURE).

21 January 2018

1 reference

Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer

21 January 2018

1 reference

Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix

21 January 2018

1 reference

Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis.

21 January 2018

1 reference

Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer

21 January 2018

1 reference

Case-matched comparison of contemporary radiation therapy to surgery in patients with locally advanced prostate cancer

21 January 2018

1 reference

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group

21 January 2018

1 reference

Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy

21 January 2018

1 reference

A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.

21 January 2018

1 reference

Time trends and local variation in primary treatment of localized prostate cancer

21 January 2018

1 reference

Radical prostatectomy versus observation for localized prostate cancer

21 January 2018

1 reference

Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial

21 January 2018

1 reference

Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial

21 January 2018

1 reference

Long-term outcomes of radical prostatectomy with multimodal adjuvant therapy in men with a preoperative serum prostate-specific antigen level > or =50 ng/mL.

21 January 2018

1 reference

Radiation therapy and androgen deprivation in the management of high risk prostate cancer

21 January 2018

1 reference

Treatment strategies for high-risk locally advanced prostate cancer

21 January 2018

1 reference

Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.

21 January 2018

1 reference

Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer

21 January 2018

1 reference

Duration of androgen suppression in the treatment of prostate cancer

21 January 2018

1 reference

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.

21 January 2018

1 reference

Guideline for the management of clinically localized prostate cancer: 2007 update.

21 January 2018

1 reference

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease

21 January 2018

1 reference

An analysis of radical prostatectomy in advanced stage and high-grade prostate cancer.

21 January 2018

1 reference

Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy

21 January 2018

1 reference

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy

21 January 2018

1 reference

Impact of prostate-specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8-10 cancers

21 January 2018

1 reference

The surgical learning curve for prostate cancer control after radical prostatectomy.

21 January 2018

1 reference

Pelvic lymph node dissection in prostate cancer

21 January 2018

1 reference

Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy

21 January 2018

1 reference

MR imaging in local staging of prostate cancer

21 January 2018

1 reference

Early oncological outcomes of robot-assisted radical prostatectomy for high-grade prostate cancer.

21 January 2018

1 reference

Lymph node dissection during robot-assisted radical prostatectomy: where do we stand?

21 January 2018

1 reference

Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial

21 January 2018

1 reference

Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.

21 January 2018

1 reference

Post-prostatectomy radiation therapy: consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group

21 January 2018

1 reference

A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma

21 January 2018

1 reference

Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 study

21 January 2018

1 reference

Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancer

21 January 2018

1 reference

Long-term follow-up of a neoadjuvant chemohormonal taxane-based phase II trial before radical prostatectomy in patients with non-metastatic high-risk prostate cancer

21 January 2018

1 reference

Timing is everything: preclinical evidence supporting simultaneous rather than sequential chemohormonal therapy for prostate cancer

21 January 2018

1 reference

Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancer

21 January 2018

1 reference

Salvage of locally recurrent prostate cancer after definitive radiotherapy.

21 January 2018

1 reference

Impact of prior prostate radiation on complications after radical prostatectomy

21 January 2018

1 reference

Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer

21 January 2018

1 reference

Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration

21 January 2018

1 reference

Inaccuracies in assignment of clinical stage for localized prostate cancer

21 January 2018

1 reference

Radical prostatectomy for high-risk prostate cancer defined by preoperative criteria: oncologic follow-up in national multicenter study in 813 patients and assessment of easy-to-use prognostic substratification

21 January 2018

1 reference

Poorly differentiated prostate cancer treated with radical prostatectomy: long-term outcome and incidence of pathological downgrading

21 January 2018

1 reference

The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomy.

21 January 2018

1 reference

Changing nature of high risk patients undergoing radical prostatectomy

21 January 2018

1 reference

Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer

21 January 2018

1 reference

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

21 January 2018

1 reference

Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.

21 January 2018

1 reference

Improving the management of patients with prostate cancer receiving long-term androgen deprivation therapy

21 January 2018

1 reference

Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer

21 January 2018

1 reference

Early versus delayed endocrine treatment of pN1-3 M0 prostate cancer without local treatment of the primary tumor: results of European Organisation for the Research and Treatment of Cancer 30846--a phase III study

21 January 2018

1 reference

Does local treatment of the prostate in advanced and/or lymph node metastatic disease improve efficacy of androgen-deprivation therapy? A systematic review

21 January 2018

1 reference

Preparing the "soil": the premetastatic niche

21 January 2018

1 reference

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts.

21 January 2018

1 reference

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer

21 January 2018

1 reference

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

21 January 2018

1 reference

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

Radical prostatectomy for high-risk clinically localized prostate cancer: a prospective single institution series.

21 January 2018

1 reference

Trends and predictors of aggressive therapy for clinical locally advanced prostate carcinoma

21 January 2018

1 reference